Edward Fox
Stanford Medicine · 82 works · 5,452 citations · h-index 32
Top works
- Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families
- Detecting ultralow-frequency mutations by Duplex Sequencing
- Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3
- Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families.
- Mutational Heterogeneity in Human Cancers: Origin and Consequences
- Accuracy of Next Generation Sequencing Platforms
- Interaction of soft condensed materials with living cells: Phenotype/transcriptome correlations for the hydrophobic effect
- CENP‐F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer
- Identification and characterization of a novel activating mutation of the FLT3 tyrosine kinase in AML
- Cancer Genome Sequencing—An Interim Analysis
- Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies
- Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene
- Combination of SELDI-TOF-MS and Data Mining Provides Early-stage Response Prediction for Rectal Tumors Undergoing Multimodal Neoadjuvant Therapy
- Hypoxia induces mitochondrial mutagenesis and dysfunction in inflammatory arthritis
- Human suppressor T cells: Induction, differentiation, and regulatory functions
- Mutational spectra of aflatoxin B 1 in vivo establish biomarkers of exposure for human hepatocellular carcinoma
- Growth arrest-specific gene 6 expression in human breast cancer
- Opposing immunoregulatory functions of CD8+ lymphocytes: a requirement for monocytes in suppressor cell induction.
- Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL– and mutant FLT3-expressing cells
- Cellular requirements for induction of human primary proliferative responses to trinitrophenyl-modified cells.